Natural Killer T Cells Regulate the Development of Asthma

REFERENCES

• D. Umetsu, J. McIntire, C. Macaubas, O. Akbari, and R. DeKruyff, Asthma: An epidemic of dysregulated immunity, Nat. Immunol., 3: 715–720, 2002.
   PubMed Web of Science ®Google Scholar
• K.B. Weiss and S.D. Sullivan, The health economics of asthma and rhinitis. I. Assessing the economic impact, J. Allergy Clin. Immunol., 107: 3–8, 2001.
   PubMed Web of Science ®Google Scholar
• D. Zaas and D.A. Schwartz, Genetics of environmental asthma, Semin. Respir. Crit. Care Med., 24: 185–196, 2003.
   Google Scholar
• M.N. Blumenthal, The role of genetics in the development of asthma and atopy, Curr. Opin. Allergy Clin. Immunol., 5: 141–145, 2005.
   PubMed Web of Science ®Google Scholar
• M. Wills-Karp, Immunologic basis of antigen-induced airway hyperresponsiveness, Annu. Rev. Immunol., 17: 255–281, 1999.
   PubMed Web of Science ®Google Scholar
• A.B. Kay, Allergy and allergic diseases. First of two parts, N. Engl. J. Med., 344: 30–37, 2001.
   PubMed Web of Science ®Google Scholar
• C.A. Herrick and K. Bottomly, To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol., 3: 405–412, 2003.
   PubMed Web of Science ®Google Scholar
• D.S. Robinson, Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A.M. Bentley, C. Corrigan, S.R. Durham, and A.B. Kay, Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med., 326: 298–304, 1992.
   PubMed Web of Science ®Google Scholar
• O. Akbari, P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu, Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med., 9: 582–588, 2003.
   PubMed Web of Science ®Google Scholar
• O. Akbari, J.L. Faul, E.G. Hoyte, G.J. Berry, J. Wahlstrom, M. Kronenberg, R.H. DeKruyff, and D.T. Umetsu, CD4 + invariant T-cell-receptor + natural killer T cells in bronchial asthma. N. Engl. J. Med., 354: 1117–1129, 2006.
   PubMed Web of Science ®Google Scholar
• M. Lisbonne, S. Diem, A. de Castro Keller, J. Lefort, L. Araujo, P. Hachem, J. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, P. Van Endert, M. Dy, P. Askenase, M. Russo, B. Vargaftig, A. Herbelin, and M. Leite-de-Moraes, Cutting edge: Invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model, J. Immunol., 171: 1637–1641, 2003.
   PubMed Web of Science ®Google Scholar
• L. Bilenki, J. Yang, Y. Fan, S. Wang, and X. Yang, Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production, Eur. J. Immunol., 34: 345–354, 2004.
   PubMed Web of Science ®Google Scholar
• D.I. Godfrey and M. Kronenberg, Going both ways: Immune regulation via CD1d-dependent NKT cells, J. Clin. Invest., 114: 1379–1388, 2004.
   PubMed Web of Science ®Google Scholar
• M. Taniguchi, M. Harada, S. Kojo, T. Nakayama, and H. Wakao, The regulatory role of Valpha14 NKT cells in innate and acquired immune response, Annu. Rev. Immunol., 21: 483–513, 2003.
   PubMed Web of Science ®Google Scholar
• M.A. Exley and M.J. Koziel, To be or not to be NKT: Natural killer T cells in the liver, Hepatology, 40: 1033–1040, 2004.
   PubMed Web of Science ®Google Scholar
• K. Seino and M. Taniguchi, Functionally distinct NKT cell subsets and subtypes, J. Exp. Med., 202: 1623–1626, 2005.
   PubMed Web of Science ®Google Scholar
• I.J. Fuss, F. Heller, M. Boirivant, F. Leon, M. Yoshida, S. Fichtner-Feigl, Z. Yang, M. Exley, A. Kitani, R.S. Blumberg, P. Mannon, and W. Strober, Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis, J. Clin. Invest., 113: 1490–1497, 2004.
   PubMed Web of Science ®Google Scholar
• M. Terabe, S. Matsui, N. Noben-Trauth, H. Chen, C. Watson, D. Donaldson, D. Carbone, W. Paul, and J. Berzofsky, NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway, Nat. Immunol., 1: 515–520, 2000.
   PubMed Web of Science ®Google Scholar
• M. Brigl and M.B. Brenner, CD1: Antigen presentation and T cell function, Annu. Rev. Immunol., 22: 817–890, 2004.
   PubMed Web of Science ®Google Scholar
• Y. Kinjo, D. Wu, G. Kim, G.-W. Xing, M. Poles, D.D. Ho, M. Tsuji, K. Kawahara, C.-H. Wong, and M. Kronenberg, Recognition of bacterial glycosphingolipids by natural killer T cells, Nature, 434: 520–525, 2005.
   PubMed Web of Science ®Google Scholar
• D.P. Zhou, J. Mattner, C. Cantu, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, S. Teneberg, D.C. Wang, R.L. Proia, S.B. Levery, P.B. Savage, L. Teyton, and A. Bendelac, Lysosomal glycosphingolipid recognition by NKT cells, Science, 306: 1786–1789, 2004.
   PubMed Web of Science ®Google Scholar
• M. Kronenberg and A. Rudensky, Regulation of immunity by self-reactive T cells, Nature, 435: 598–604, 2005.
   PubMed Web of Science ®Google Scholar
• N.Y. Crowe, J.M. Coquet, S.P. Berzins, K. Kyparissoudis, R. Keating, D.G. Pellicci, Y. Hayakawa, D.I. Godfrey, and M.J. Smyth, Differential antitumor immunity mediated by NKT cell subsets in vivo, J. Exp. Med., 202: 1279–1288, 2005.
   PubMed Web of Science ®Google Scholar
• J. Cui, N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, Y. Tanaka, M. Taniguchi, and T. Nakayama, Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells, J. Exp. Med., 190: 783–792, 1999.
   PubMed Web of Science ®Google Scholar
• M. Korsgren, C.G. Persson, F. Sundler, T. Bjerke, T. Hansson, B.J. Chambers, S. Hong, L. Van Kaer, H.G. Ljunggren, and O. Korsgren, Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice, J. Exp. Med., 189: 553–562, 1999.
   PubMed Web of Science ®Google Scholar
• D. Brown, D. Fowell, D. Corry, T. Wynn, N. Moskowitz, A. Cheever, R. Locksley, and S. Reiner, Beta 2-microglobulin-dependent NK1.1 + T cells are not essential for T helper cell 2 immune responses, J. Exp. Med., 184: 1295–1304, 1996.
   PubMed Web of Science ®Google Scholar
• Y. Zhang, K.H. Rogers, and D.B. Lewis, Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses, J. Exp. Med., 184: 1507–1512, 1996.
   PubMed Web of Science ®Google Scholar
• M. Amano, N. Baumgarth, M.D. Dick, L. Brossay, M. Kronenberg, L.A. Herzenberg, and S. Strober, CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: Beta 2-microglobulin-dependent and independent forms, J. Immunol., 161: 1710–1717, 1998.
   PubMed Web of Science ®Google Scholar
• M. Maeda, A. Shadeo, A. MacFadyen, and F. Takei, CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells, J. Immunol., 172: 6115–6122, 2004.
   PubMed Web of Science ®Google Scholar
• H.S. Kim, J. Garcia, M. Exley, K.W. Johnson, S.P. Balk, and R.S. Blumberg, Biochemical characterization of CD1d expression in the absence of beta2-microglobulin, J. Biol. Chem., 274: 9289–9295, 1999.
   PubMedGoogle Scholar
• S.T. Smiley, M.H. Kaplan, and M.J. Grusby, Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells, Science, 275: 977–979, 1997.
   PubMedGoogle Scholar
• J.O. Kim, D.H. Kim, W.S. Chang, C.W. Hong, S.H. Park, S.H. Kim, and C.Y. Kang, Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model, J. Allergy Clin. Immunol., 114: 1332–1338, 2004.
   PubMed Web of Science ®Google Scholar
• T. Yoshimoto, A. Bendelac, J. Hu-Li, and W.E. Paul, Defective IgE production by SJL mice is linked to the absence of CD4 +, NK1.1 + T cells that promptly produce interleukin 4, Proc. Natl. Acad. Sci. U.S.A., 92: 11931–11934, 1995.
   PubMed Web of Science ®Google Scholar
• T. Yoshimoto, A. Bendelac, C. Watson, J. Hu-Li, and W.E. Paul, Role of NK1.1 + T cells in a TH2 response and in immunoglobulin E production, Science, 270: 1845–1847, 1995.
   PubMed Web of Science ®Google Scholar
• A. Bendelac, R.D. Hunziker, and O. Lantz, Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells, J. Exp. Med., 184: 1285–1293, 1996.
   PubMed Web of Science ®Google Scholar
• E.H. Meyer, S. Goya, O. Akbari, G.J. Berry, P.B. Savage, M. Kronenberg, T. Nakayama, R.H. DeKruyff, and D.T. Umetsu, Glycolipid activation of invariant T cell receptor + NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4 + T cells, Proc. Natl. Acad. Sci. U.S.A., 103: 2782–2787, 2006.
   PubMed Web of Science ®Google Scholar
• G. Galli, S. Nuti, S. Tavarini, L. Galli-Stampino, C. De Lalla, G. Casorati, P. Dellabona, and S. Abrignani, Innate immune responses support adaptive immunity: NKT cells induce B cell activation, Vaccine, 21(Suppl 2): S48–54, 2003.
   Google Scholar
• J. Mattner, K.L. DeBord, N. Ismail, R.D. Goff, C.C. III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, K. Hoebe, O. Schneewind, D. Walker, B. Beutler, L. Teyton, P.B. Savage, and A. Bendelac, Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections, Nature, 434: 525–529, 2005.
   PubMed Web of Science ®Google Scholar
• J. Stein-Streilein, Invariant NKT cells as initiators, licensors, and facilitators of the adaptive immune response, J. Exp. Med., 198: 1779–1783, 2003.
   Google Scholar
• M. Kronenberg, Toward an understanding of NKT cell biology: Progress and paradoxes, Annu. Rev. Immunol., 23: 877–900, 2005.
   PubMed Web of Science ®Google Scholar
• K. Kawakami, Y. Kinjo, K. Uezu, S. Yara, K. Miyagi, Y. Koguchi, T. Nakayama, M. Taniguchi, and A. Saito, Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection, J. Immunol., 167: 6525–6532, 2001.
   PubMed Web of Science ®Google Scholar
• D.S. Hansen, M.A. Siomos, L. Buckingham, A.A. Scalzo, and L. Schofield, Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex, Immunity, 18: 391–402, 2003.
   Google Scholar
• M.S. Duthie, M. Kahn, M. White, R.P. Kapur, and S.J. Kahn, Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection, Infect. Immun., 73: 181–192, 2005.
   PubMed Web of Science ®Google Scholar
• H. Ishikawa, H. Hisaeda, M. Taniguchi, T. Nakayama, T. Sakai, Y. Maekawa, Y. Nakano, M. Zhang, T. Zhang, M. Nishitani, M. Takashima, and K. Himeno, CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major, Int. Immunol., 12: 1267–1274, 2000.
   PubMedGoogle Scholar
• T. Mallevaey, J.P. Zanetta, C. Faveeuw, J. Fontaine, E. Maes, F. Platt, M. Capron, M.L. de-Moraes, and F. Trottein, Activation of invariant NKT cells by the helminth parasite schistosoma mansoni, J. Immunol., 176: 2476–2485, 2006.
   PubMedGoogle Scholar
• E. Agea, A. Russano, O. Bistoni, R. Mannucci, I. Nicoletti, L. Corazzi, A. Postle, G. De Libero, S. Porcelli, and F. Spinozzi, Human CD1-restricted T cell recognition of lipids from pollens, J. Exp. Med., 202: 295–308, 2005.
   PubMed Web of Science ®Google Scholar
• G. Hansen, G. Berry, R.H. DeKruyff, and D.T. Umetsu, Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation, J. Clin. Invest., 103: 175–183, 1999.
   PubMed Web of Science ®Google Scholar
• D.A. Randolph, C.J. Carruthers, S.J. Szabo, K.M. Murphy, and D.D. Chaplin, Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma, J. Immunol., 162: 2375–2383, 1999.
   PubMed Web of Science ®Google Scholar
• L. Cohn, R.J. Homer, A. Marinov, J. Rankin, and K. Bottomly, Induction of airway mucus production By T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production, J. Exp. Med., 186: 1737–1747, 1997.
   PubMed Web of Science ®Google Scholar
• Y. Sen, B. Yongyi, H. Yuling, X. Luokun, H. Li, X. Jie, D. Tao, Z. Gang, L. Junyan, H. Chunsong, X. Zhang, J. Youxin, G. Feili, J. Boquan, and T. Jinquan, V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3 + T cells upon CD226 engagement, J. Immunol., 175: 4914–4926, 2005.
   PubMed Web of Science ®Google Scholar
• Y. Ikegami, A. Yokoyama, Y. Haruta, K. Hiyama, and N. Kohno, Circulating natural killer T cells in patients with asthma, J. Asthma, 41: 877–882, 2004.
   PubMed Web of Science ®Google Scholar
• J.D. Milner, S.C. Kent, T.A. Ashley, S.B. Wilson, J.L. Strominger, and D.A. Hafler, Differential responses of invariant V alpha 24 J alpha Q T cells and MHC class II-restricted CD4 + T cells to dexamethasone, J. Immunol., 163: 2522–2529, 1999.
   Google Scholar
• K. Tamada, M. Harada, K. Abe, T. Li, and K. Nomoto, IL-4-producing NK1.1 + T cells are resistant to glucocorticoid-induced apoptosis: Implications for the Th1/Th2 balance, J. Immunol., 161: 1239–1247, 1998.
   PubMed Web of Science ®Google Scholar
• I.M. Adcock and K. Ito, Steroid resistance in asthma: A major problem requiring novel solutions or a non-issue? Curr. Opin. Pharmacol., 4: 257–262, 2004.
   PubMed Web of Science ®Google Scholar
• K. Ito, K.F. Chung, and I.M. Adcock, Update on glucocorticoid action and resistance, J. Allergy Clin. Immunol., 117: 522–543, 2006.
   PubMed Web of Science ®Google Scholar
• P. Hachem, M. Lisbonne, M.L. Michel, S. Diem, S. Roongapinun, J. Lefort, G. Marchal, A. Herbelin, P.W. Askenase, M. Dy, and M.C. Leite-de-Moraes, Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: Role of IFN-gamma, Eur. J. Immunol., 35: 2793–2802, 2005.
   PubMed Web of Science ®Google Scholar
• H. Matsuda, T. Suda, J. Sato, T. Nagata, Y. Koide, K. Chida, and H. Nakamura, alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation, Am. J. Respir. Cell Mol. Biol., 33: 22–31, 2005.
   PubMed Web of Science ®Google Scholar
• Y. Morishima, Y. Ishii, T. Kimura, A. Shibuya, K. Shibuya, A.E. Hegab, T. Iizuka, T. Kiwamoto, Y. Matsuno, T. Sakamoto, A. Nomura, M. Taniguchi, and K. Sekizawa, Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide, Eur. J. Immunol., 35: 2803–2814, 2005.
   PubMed Web of Science ®Google Scholar
• V.V. Parekh, M.T. Wilson, D. Olivares-Villagomez, A.K. Singh, L. Wu, C.R. Wang, S. Joyce, and L. Van Kaer, Glycolipid antigen induces long-term natural killer T cell anergy in mice, J. Clin. Invest., 115: 2572–2583, 2005.
   PubMed Web of Science ®Google Scholar
• J.L. Matsuda, L. Gapin, J.L. Baron, S. Sidobre, D.B. Stetson, M. Mohrs, R.M. Locksley, and M. Kronenberg, Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo, Proc. Natl. Acad. Sci. U.S.A., 100: 8395–8400, 2003.
   PubMed Web of Science ®Google Scholar
• Z.Y. Wang, S. Kusam, V. Munugalavadla, R. Kapur, R.R. Brutkiewicz, and A.L. Dent, Regulation of Th2 cytokine expression in NKT cells: Unconventional use of Stat6, GATA-3, and NFAT2, J. Immunol., 176: 880–888, 2006.
   Google Scholar
• M.A. Sherman, V.H. Secor, S.K. Lee, R.D. Lopez, and M.A. Brown, STAT6-independent production of IL-4 by mast cells, Eur. J. Immunol., 29: 1235–1242, 1999.
   Google Scholar
• C. Kim, B. Johnston, and E. Butcher, Trafficking machinery of NKT cells: Shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity, Blood, 100: 11–16, 2002.
   PubMedGoogle Scholar
• J.E. Gumperz, S. Miyake, T. Yamamura, and M.B. Brenner, Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining, J. Exp. Med., 195: 625–636, 2002.
   PubMed Web of Science ®Google Scholar
• J.L. Matsuda, L. Gapin, N. Fazilleau, K. Warren, O.V. Naidenko, and M. Kronenberg, Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size, Proc. Natl. Acad. Sci. U.S.A., 98: 12636–12641, 2001.
   Google Scholar
• S. Sharif, G.A. Arreaza, P. Zucker, Q. Mi, J. Sondhi, O.V. Naidenko, M. Kronenberg, Y. Koezuka, T.L. Delovitch, J.M. Gombert, M. Leite-De-Moraes, C. Gouarin, R. Zhu, A. Hameg, T. Nakayama, M. Taniguchi, F. Lepault, A. Lehuen, J.F. Bach, and A. Herbelin, Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes, Nat. Med., 7: 1057–1062, 2001.
   PubMed Web of Science ®Google Scholar
• Q.S. Mi, D. Ly, P. Zucker, M. McGarry, and T.L. Delovitch, Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells, Diabetes, 53: 1303–1310, 2004.
   PubMed Web of Science ®Google Scholar
• K. Benlagha, T. Kyin, A. Beavis, L. Teyton, and A. Bendelac, A thymic precursor to the NK T cell lineage, Science, 296: 553–555, 2002.
   PubMed Web of Science ®Google Scholar
• H.R. MacDonald, Development and selection of NKT cells, Curr. Opin. Immunol., 14: 250–254, 2002.
   PubMed Web of Science ®Google Scholar
• K. Miyamoto, S. Miyake, and T. Yamamura, A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells, Nature, 413: 531–534, 2001.
   PubMed Web of Science ®Google Scholar
• S. Oki, A. Chiba, T. Yamamura, and S. Miyake, The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells, J. Clin. Invest., 113: 1631–1640, 2004.
   PubMed Web of Science ®Google Scholar
• J. Schmieg, G. Yang, R.W. Franck, and M. Tsuji, Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide, J. Exp. Med., 198: 1631–1641, 2003.
   PubMed Web of Science ®Google Scholar
• J. Schmieg, G. Yang, R.W. Franck, N. Van Rooijen, and M. Tsuji, Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion, Proc. Natl. Acad. Sci. U.S.A., 102: 1127–1132, 2005.
   PubMed Web of Science ®Google Scholar
• J.S. Bezbradica, A.K. Stanic, N. Matsuki, H. Bour-Jordan, J.A. Bluestone, J.W. Thomas, D. Unutmaz, L. Van Kaer, and S. Joyce, Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo, J. Immunol., 174: 4696–4705, 2005.
   PubMed Web of Science ®Google Scholar
• F. Lan, D. Zeng, M. Higuchi, P. Huie, J.P. Higgins, and S. Strober, Predominance of NK1.1 + TCR alpha beta + or DX5 + TCR alpha beta + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: “Natural suppressor” cells, J. Immunol., 167: 2087–2096, 2001.
   PubMed Web of Science ®Google Scholar
• R. Lowsky, T. Takahashi, Y.P. Liu, S. Dejbakhsh-Jones, F.C. Grumet, J.A. Shizuru, G.G. Laport, K.E. Stockerl-Goldstein, L.J. Johnston, R.T. Hoppe, D.A. Bloch, K.G. Blume, R.S. Negrin, and S. Strober, Protective conditioning for acute graft-versus-host disease, N. Engl. J. Med., 353: 1321–1331, 2005.
   PubMed Web of Science ®Google Scholar
• F. Heller, I. Fuss, E. Nieuwenhuis, R. Blumberg, and W. Strober, Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells, Immunity, 17: 629–638, 2002.
   PubMed Web of Science ®Google Scholar
• Y. Oishi, A. Sakamoto, K. Kurasawa, H. Nakajima, A. Nakao, N. Nakagawa, E. Tanabe, Y. Saito, and I. Iwamoto, CD4-CD8- T cells bearing invariant Valpha24JalphaQ TCR alpha-chain are decreased in patients with atopic diseases, Clin. Exp. Immunol., 119: 404–411, 2000.
   PubMedGoogle Scholar
• T. Takahashi, K. Nakamura, S. Chiba, Y. Kanda, K. Tamaki, and H. Hirai, V alpha 24 + natural killer T cells are markedly decreased in atopic dermatitis patients, Hum. Immunol., 64: 586–592, 2003.
   PubMed Web of Science ®Google Scholar
• A. Magnan, L. Mely, S. Prato, D. Vervloet, F. Romagne, C. Camilla, A. Necker, B. Casano, F. Montero-Jullian, V. Fert, B. Malissen, and P. Bongrand, Relationships between natural T cells, atopy, IgE levels, and IL-4 production, Allergy, 55: 286–290, 2000.
   Google Scholar
• R.A. Campos, M. Szczepanik, A. Itakura, M. Akahira-Azuma, S. Sidobre, M. Kronenberg, and P.W. Askenase, Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity, J. Exp. Med., 198: 1785–1796, 2003.
   PubMed Web of Science ®Google Scholar
• E.E. Nieuwenhuis, S. Gillessen, R.J. Scheper, M.A. Exley, M. Taniguchi, S.P. Balk, J.L. Strominger, G. Dranoff, R.S. Blumberg, and S.B. Wilson, CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity, Exp. Dermatol., 14: 250–258, 2005.
   PubMedGoogle Scholar
• L.J. Saubermann, P. Beck, Y.P. De Jong, R.S. Pitman, M.S. Ryan, H.S. Kim, M. Exley, S. Snapper, S.P. Balk, S.J. Hagen, O. Kanauchi, K. Motoki, T. Sakai, C. Terhorst, Y. Koezuka, D.K. Podolsky, and R.S. Blumberg, Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice, Gastroenterology, 119: 119–128, 2000.
   PubMed Web of Science ®Google Scholar